Richard Lee, CEO of LOTTE BIOLOGICS, delivered a lecture to the faculty at KAIST in Daejeon. 

His presentation was titled 'Paradigm Shifts in the CDMO Market and New Business Ventures.' He also highlighted LOTTE BIOLOGICS' vision to work together to support the growth of the domestic bio-pharmaceutical industry in the global market.

The session prompted an engaging Q&A with KAIST faculty members, who showed a profound interest in the topic presented. We trust that this valuable exchange has contributed to expanding insights and enriching perspectives on the bio-pharmaceutical industry.